CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the US

Bausch Health Companies Inc. Common Stock 0.00% Pre

Bausch Health Companies Inc. Common Stock

BHC

6.13

6.10

0.00%

-0.49% Pre

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its dermatology business, Ortho Dermatologics, today announced the U.S. launch of CABTREO™ (clindamycin, adapalene, benzoyl peroxide) Topical Gel, 1.2%/0.15%/3.1% indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via